Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Ophthalmology. 2019 Mar 21;126(10):1350–1355. doi: 10.1016/j.ophtha.2019.03.019

Table 1.

Inclusion and exclusion criteria for companies offering direct-to-consumer “cell therapy” for ocular conditions.

Inclusion Criteria Exclusion Criteria
U.S.-based companies International companies
Marketing “cell therapy” directly to consumer via the Internet Administer cell therapy outside of U.S.
Websites that can be data-mined Mail-order delivery of cell therapy
Advertise treatment for ocular conditions Cell-processing medical devices